Adagene Stock Buy Hold or Sell Recommendation
| ADAG Stock | USD 2.19 0.07 3.10% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Adagene is 'Strong Sell'. Macroaxis provides Adagene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Adagene positions.
Check out Adagene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide. Note, we conduct extensive research on individual companies such as Adagene and provide practical buy, sell, or hold advice based on investors' constraints. Adagene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Adagene |
Execute Adagene Buy or Sell Advice
The Adagene recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adagene. Macroaxis does not own or have any residual interests in Adagene or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adagene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Adagene Trading Alerts and Improvement Suggestions
| Adagene generated a negative expected return over the last 90 days | |
| Adagene has high historical volatility and very poor performance | |
| Adagene has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.11 M. Net Loss for the year was (18.95 M) with profit before overhead, payroll, taxes, and interest of 10.18 M. | |
| Adagene currently holds about 168.04 M in cash with (28.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from zacks.com: Is Adagene Stock Outpacing Its Medical Peers This Year |
Adagene Returns Distribution Density
The distribution of Adagene's historical returns is an attempt to chart the uncertainty of Adagene's future price movements. The chart of the probability distribution of Adagene daily returns describes the distribution of returns around its average expected value. We use Adagene price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adagene returns is essential to provide solid investment advice for Adagene.
| Mean Return | 0.04 | Value At Risk | -9.52 | Potential Upside | 8.30 | Standard Deviation | 6.29 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adagene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Adagene Stock Institutional Investors
| Shares | Royal Bank Of Canada | 2024-06-30 | 8.3 K | Ubs Group Ag | 2024-06-30 | 164 | Qube Research & Technologies | 2024-06-30 | 47.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Springbok Capital Management, Llc | 2024-06-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | Artal Group S A | 2024-06-30 | 0.0 | Wuxi Apptec Co Ltd | 2024-09-30 | 4 M | Fidelity International Ltd | 2024-06-30 | 3.8 M | Sc China Holding Ltd | 2024-06-30 | 1.3 M | Fmr Inc | 2024-09-30 | 1.3 M |
Adagene Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 25M | 8M | (2.5M) | (686.0K) | (77.4K) | (73.5K) | |
| Change In Cash | 76.5M | (17.4M) | 99.2M | (30.6M) | (33.8M) | (32.1M) | |
| Free Cash Flow | (18.3M) | (29.5M) | (45.9M) | (49.3M) | (28.5M) | (30.0M) | |
| Depreciation | 816.7K | 858.4K | 1.1M | 1.4M | 1.2M | 1.2M | |
| Other Non Cash Items | (1.2M) | 645.0K | (9.9K) | (2.5M) | (1.4M) | (1.4M) | |
| Capital Expenditures | 151.8K | 935.2K | 2.5M | 690.9K | 85.0K | 80.8K | |
| Net Income | (16.4M) | (42.4M) | (73.2M) | (80.0M) | (18.9M) | (19.9M) | |
| End Period Cash Flow | 92.5M | 75.2M | 174.4M | 143.8M | 109.9M | 112.2M |
Adagene Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adagene or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adagene's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adagene stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 0.45 | |
σ | Overall volatility | 6.22 | |
Ir | Information ratio | -0.01 |
Adagene Volatility Alert
Adagene is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Adagene's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Adagene's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Adagene Fundamentals Vs Peers
Comparing Adagene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adagene's direct or indirect competition across all of the common fundamentals between Adagene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adagene or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adagene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Adagene to competition |
| Fundamentals | Adagene | Peer Average |
| Return On Equity | -0.46 | -0.31 |
| Return On Asset | -0.2 | -0.14 |
| Operating Margin | (45.35) % | (5.51) % |
| Current Valuation | 25.17 M | 16.62 B |
| Shares Outstanding | 44.27 M | 571.82 M |
| Shares Owned By Insiders | 10.65 % | 10.09 % |
| Shares Owned By Institutions | 25.54 % | 39.21 % |
| Number Of Shares Shorted | 12.29 K | 4.71 M |
| Price To Book | 1.77 X | 9.51 X |
| Price To Sales | 122.65 X | 11.42 X |
| Revenue | 18.11 M | 9.43 B |
| Gross Profit | 10.18 M | 27.38 B |
| EBITDA | (14.95 M) | 3.9 B |
| Net Income | (18.95 M) | 570.98 M |
| Cash And Equivalents | 168.04 M | 2.7 B |
| Cash Per Share | 3.87 X | 5.01 X |
| Total Debt | 22.31 M | 5.32 B |
| Debt To Equity | 0.15 % | 48.70 % |
| Current Ratio | 3.10 X | 2.16 X |
| Book Value Per Share | 1.28 X | 1.93 K |
| Cash Flow From Operations | (28.45 M) | 971.22 M |
| Short Ratio | 0.33 X | 4.00 X |
| Earnings Per Share | (0.72) X | 3.12 X |
| Target Price | 10.54 | |
| Number Of Employees | 174 | 18.84 K |
| Beta | 0.58 | -0.15 |
| Market Capitalization | 108.46 M | 19.03 B |
| Total Asset | 115.73 M | 29.47 B |
| Retained Earnings | (277.75 M) | 9.33 B |
| Working Capital | 81.99 M | 1.48 B |
| Net Asset | 115.73 M |
Adagene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adagene . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 623.66 | |||
| Daily Balance Of Power | (0.54) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 2.22 | |||
| Day Typical Price | 2.21 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.07) |
About Adagene Buy or Sell Advice
When is the right time to buy or sell Adagene? Buying financial instruments such as Adagene Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Adagene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Advertising Thematic Idea Now
Advertising
Companies specializing in advertising, marketing and advertising services. The Advertising theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Advertising Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Adagene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share 0.019 | Quarterly Revenue Growth (0.85) | Return On Assets (0.20) | Return On Equity (0.46) |
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.